Literature DB >> 8609422

Encephalitogenic epitopes of myelin basic protein, proteolipid protein, myelin oligodendrocyte glycoprotein for experimental allergic encephalomyelitis induction in Biozzi ABH (H-2Ag7) mice share an amino acid motif.

S Amor1, J K O'Neill, M M Morris, R M Smith, D C Wraith, N Groome, P J Travers, D Baker.   

Abstract

Myelin basic protein (MBP) and synthetic MBP peptides were screened for their ability to induce experimental allergic encephalomyelitis in Biozzi ABH (H-2Ag7) mice. In contrast to the failure of native MBP to induce experimental allergic encephalomyelitis, the use of overlapping MBP peptides revealed epitopes within MBP 12-26 and MBP 21-35, which induced mild disease. In comparison with disease induced by spinal cord homogenate or peptides of myelin oligodendrocyte glycoprotein (MOG) or proteolipid protein (PLP), the low incidence indicates that, at least in ABH mice, MBP is a minor encephalitogen. However, the data suggest the presence of a peptide core between MBP 21-26 (HARHGF), which contains similar elements to the previously defined encephalitogenic MOG 1-22 and PLP 56-70 peptides. The fine specificity of these epitopes was further investigated using frame-shifted peptides, which indicated cores between MOG 9-15 (GYPIRAL) and PLP 62-68 (NVIHAFQ). Based on these pathogenic peptides, a putative H-2Ag7 binding motif is suggested that contains a series of hydrophobic, basic, small, and large hydrophobic residues within a 6 to 7 amino acid core. The core and particular importance of these four residues in PLP 56-70 was confirmed in vitro using amino acid substitution studies. These findings support many of the predictions made by computer modeling of peptide:H-2Ag7 interactions. This may have relevance in the design of strategies in the treatment of experimental autoimmune diseases in animals that express this haplotype.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8609422

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  16 in total

1.  The lack of consensus for I-A(g7)-peptide binding motifs: is there a requirement for anchor amino acid side chains?

Authors:  E Carrasco-Marin; O Kanagawa; E R Unanue
Journal:  Proc Natl Acad Sci U S A       Date:  1999-07-20       Impact factor: 11.205

Review 2.  IL-17 producing T cells in mouse models of multiple sclerosis and rheumatoid arthritis.

Authors:  Bernadette Pöllinger
Journal:  J Mol Med (Berl)       Date:  2012-01-10       Impact factor: 4.599

Review 3.  Developing therapeutics for the treatment of multiple sclerosis.

Authors:  David J Virley
Journal:  NeuroRx       Date:  2005-10

4.  Experimental Autoimmune Encephalomyelitis in Mice.

Authors:  Rachael L Terry; Igal Ifergan; Stephen D Miller
Journal:  Methods Mol Biol       Date:  2016

5.  Neurofilament light as an immune target for pathogenic antibodies.

Authors:  Fabiola Puentes; Baukje J van der Star; Stephanie D Boomkamp; Markus Kipp; Louis Boon; Isabel Bosca; Joel Raffel; Sharmilee Gnanapavan; Paul van der Valk; Jodie Stephenson; Susan C Barnett; David Baker; Sandra Amor
Journal:  Immunology       Date:  2017-08-11       Impact factor: 7.397

6.  Lovastatin inhibits brain endothelial cell Rho-mediated lymphocyte migration and attenuates experimental autoimmune encephalomyelitis.

Authors:  John Greenwood; David Baker; Peter Adamson; Claire E Walters; Gareth Pryce; Naheed Kanuga; Evelyne Beraud
Journal:  FASEB J       Date:  2003-03-05       Impact factor: 5.191

7.  Passive experimental autoimmune encephalomyelitis in C57BL/6 with MOG: evidence of involvement of B cells.

Authors:  Francesco Mannara; Tony Valente; Josep Saura; Francesc Graus; Albert Saiz; Beatriz Moreno
Journal:  PLoS One       Date:  2012-12-26       Impact factor: 3.240

8.  The P66Shc/mitochondrial permeability transition pore pathway determines neurodegeneration.

Authors:  Costanza Savino; PierGiuseppe Pelicci; Marco Giorgio
Journal:  Oxid Med Cell Longev       Date:  2013-05-15       Impact factor: 6.543

9.  Predicting peptides binding to MHC class II molecules using multi-objective evolutionary algorithms.

Authors:  Menaka Rajapakse; Bertil Schmidt; Lin Feng; Vladimir Brusic
Journal:  BMC Bioinformatics       Date:  2007-11-22       Impact factor: 3.169

10.  A peptide-binding motif for I-A(g7), the class II major histocompatibility complex (MHC) molecule of NOD and Biozzi AB/H mice.

Authors:  L C Harrison; M C Honeyman; S Trembleau; S Gregori; F Gallazzi; P Augstein; V Brusic; J Hammer; L Adorini
Journal:  J Exp Med       Date:  1997-03-17       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.